147
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Erlotinib-related keratopathy in a patient underwent laser in situ keratomileusis

&
Pages 257-259 | Received 06 May 2015, Accepted 01 Jul 2015, Published online: 12 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shawn P. Gallagher, Barton L. Halpern & Shanthi Sivendran. (2021) Corneal endothelial cell density in patients receiving chemotherapy. Cutaneous and Ocular Toxicology 40:3, pages 252-256.
Read now

Articles from other publishers (5)

Blake H. Fortes, Prashant D. Tailor & Lauren A. Dalvin. (2021) Ocular Toxicity of Targeted Anticancer Agents. Drugs 81:7, pages 771-823.
Crossref
Shinichi Iwamoto, Tadashi Igishi, Toru Kadowaki, Yusuke Tsubouchi, Emiko Nishikawa, Mitsuhiro Tada, Masahiro Kimura, Kanako Kobayashi & Toshikazu Ikeda. (2021) A Case of Pulmonary Adenocarcinoma with Repeated Corneal Epithelial Disorder and Herpes Simplex due to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors上皮増殖因子受容体チロシンキナーゼ阻害薬による角膜上皮障害と単純疱疹を繰り返した肺腺癌の1症例. Haigan 61:2, pages 125-129.
Crossref
Frederick “Fritz” T. Fraunfelder & Frederick “Rick” W. Fraunfelder. 2021. Drug-Induced Ocular Side Effects. Drug-Induced Ocular Side Effects 299 360 .
Keiichi Aomatsu, Koji Sugioka, Aya Kodama-Takahashi, Masahiko Fukuda, Hiroshi Mishima & Shunji Kusaka. (2020) Corneal Perforation during Combination Chemotherapy including Cetuximab in a Patient with a History of Herpetic Keratitis. Case Reports in Oncological Medicine 2020, pages 1-4.
Crossref
. (2016) Erlotinib. Reactions Weekly 1615:1, pages 94-94.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.